在非囊性纤维化支气管切除症中咳
Ahmad Kantar1,2, Woo-Jung Song3, Andrew Bush4
1Paediatric Asthma and Cough Centre, Instituti Ospedalieri Bergamaschi, Bergamo, Italy.
ERJ open research
|December 3, 2024
概括
非囊性纤维化支气管切除症 (NCFBE) 涉及气道扩张和粘液问题. 咳对于粘液清除至关重要,向粘液粘度可能是关键的治疗策略.
科学领域:
- 肺部病理学 肺部病理学
- 呼吸系统医学 呼吸系统医学
背景情况:
- 非囊性纤维化支气管炎 (NCFBE) 是一种慢性支气性肺部疾病,其特征是持续咳和气道扩张.
- 在NCFBE中,气道的变化会损害粘液的运输,降低咳的有效性.
- 粘液高粘度是NCFBE病原发生的关键因素,影响着状腺活动.
研究的目的:
- 在NCFBE中审查咳在粘液清除中的作用.
- 突出粘液超粘度作为潜在的治疗目标.
- 讨论管理NCFBE的物理治疗目标.
主要方法:
- 关于NCFBE,咳和粘液清除的现有文献的小型综述.
- 分析空气流,粘液特性和咳效率之间的相互作用.
- 对NCFBE的物理治疗方法的检查.
主要成果:
- 咳作为一个关键的备用机制的粘液清除,当状和呼吸诱导的运输受到损害.
- 粘液超粘度在NCFBE中显著损害了粘液清除.
- 物理治疗的目的是使粘液保持水分,并优化呼气气流,以有效地去除粘液.
结论:
- 向粘液类风湿学和增强粘液运输对于预防NCFBE进展和恶化至关重要.
- 专注于粘液修饰和清除的早期干预可以潜在地逆转早期支气管病变.
- 有效的NCFBE管理包括优化咳功能和物理治疗干预措施.
相关概念视频
Cystic Fibrosis: Management
141
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
141
Cystic Fibrosis: Pathogenesis
186
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
186
COPD: Management Using Bronchodilators and Corticosteroids
178
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
178
Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Chest Physiotherapy
388
Chest Physiotherapy (CPT) is a therapeutic technique used in respiratory care to improve ventilation, clear bronchial secretions, and enhance the efficiency of respiratory muscles. This therapy includes three primary procedures: postural drainage, percussion, and vibration. It can be performed on spontaneously breathing patients and those who are intubated and mechanically ventilated.
Purpose
CPT is primarily used for patients with excessive bronchial secretions who have difficulty clearing...
Purpose
CPT is primarily used for patients with excessive bronchial secretions who have difficulty clearing...
388


